Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:896098.
doi: 10.1155/2015/896098. Epub 2015 Mar 29.

Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013

Affiliations

Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013

Farhang Babamahmoodi et al. Neurol Res Int. 2015.

Abstract

Background. Herpes zoster infection is a painful worldwide disease. Inappropriate and delayed treatment causes prolongation of the disease with debilitating symptoms and postherpetic neuralgia. Method. A cross-sectional study evaluated shingles cases admitted in a teaching hospital with one-year followup in north of Iran from 2007 to 2013. Results. From 132 patients, 60.4% were male. Head and neck involvement occurred in 78 people (59.1%), thoracoabdominal region in 37 cases (28%), and extremities in 16 cases (12.1%), and one case (0.8%) got multisites involvement. 54 cases (40.9%) had predisposing factors including diabetes mellitus in 26 cases (19.7%), malignancy in 15 (11.4%), immunosuppressive medication in 7 (5.03%), HIV infection in 3 (2.3%), radiotherapy in 2 (1.5%), and tuberculosis in one patient (0.8%). The most common symptoms were pain (95.5%), weakness (56%), fever (31.1%), headache (30.3%), ocular complaints (27.3%), itching (24.2%), and dizziness (5.3%). 21 cases (15.9%) had bacterial superinfection on blistering areas and overall 18 cases (13.6%) had opium addiction. 4 cases (3.03%) died during admission because of comorbidities. Postherpetic neuralgia was reported in 56 patients (42.5%) after three months and seven cases (5%) in one-year followup. Conclusion. Shortening interval between skin lesion manifestation and starting medication can accelerate lesion improvement and decrease disease course, extension, and complication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percent of anatomical distribution of rashes.
Figure 2
Figure 2
Prevalence of the most common symptoms (percent).
Figure 3
Figure 3
The prevalence of comorbidities in patients admitted with herpes zoster (percent).

References

    1. Johnson R. W., Dworkin R. H. Treatment of herpes zoster and postherpetic neuralgia. British Medical Journal. 2003;326(7392):748–750. doi: 10.1136/bmj.326.7392.748. - DOI - PMC - PubMed
    1. Sharifi Z., Emadi Ghanjin S. The seroepidemiology of Varicella Zoster Virus (VZV) in different age groups in Tehran, Iran. Iranian Journal of Allergy, Asthma and Immunology. 2005;4(2):95–98. - PubMed
    1. Volpi A., Gatti A., Pica F., Bellino S., Marsella L. T., Sabato A. F. Clinical and psychosocialcorrelates of post-herpeticneuralgia. Journal of Medical Virology. 2008;80(9):1646–1652. doi: 10.1002/jmv.21254. - DOI - PubMed
    1. Opstelten W., Mauritz J. W., de Wit N. J., van Wijck A. J. M., Stalman W. A. B., van Essen G. A. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Family Practice. 2002;19(5):471–475. doi: 10.1093/fampra/19.5.471. - DOI - PubMed
    1. Wung P. K., Holbrook J. T., Hoffman G. S., et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. The American Journal of Medicine. 2005;118(12):1416.e9–1416.e18. doi: 10.1016/j.amjmed.2005.06.012. - DOI - PubMed

LinkOut - more resources